Drug Type Small molecule drug |
Synonyms 1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol, 6,7-Dimethyl-9-D-ribitylisoalloxazine, 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine + [27] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
RegulationOrphan Drug (European Union), Priority Review (United States) |
Molecular FormulaC17H20N4O6 |
InChIKeyAUNGANRZJHBGPY-SCRDCRAPSA-N |
CAS Registry83-88-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Vitamin B2 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Riboflavin Deficiency | China | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Pancreatic Cancer | Preclinical | China | 01 May 2024 | |
Medium Chain Acyl CoA Dehydrogenase Deficiency | Preclinical | European Union | 08 Nov 2023 | |
Astigmatism | Preclinical | United States | 01 Aug 2013 | |
Hyperopia | Preclinical | United States | 01 Aug 2013 | |
Corneal ectasia | Preclinical | - | 01 Jul 2012 | |
Keratoconus | Preclinical | United States | 01 Jul 2012 |
Phase 1/2 | 76 | (Active Treatment Arm) | dwyvsdgkos(mzqeoswxab) = vefdcjhqab nczimoutmo (ezpkrdfhyw, tcajackjnb - pwkmpnsmnz) View more | - | 10 May 2023 | ||
(Control Treatment Arm) | dwyvsdgkos(mzqeoswxab) = jchpnchlap nczimoutmo (ezpkrdfhyw, jugsyzlnmj - ftyredwagm) View more | ||||||
Not Applicable | 18 | (ynjdsilxwx) = stporzslae ccvzbdtokx (dapvgzjnxq ) View more | - | 23 Apr 2023 | |||
Not Applicable | - | - | jkvegumgks(tpjjugyspp) = qxmsykxyko subcltpnam (lxisqecjmf ) | - | 25 Aug 2019 | ||
Not Applicable | 168 | Corneal collagen crosslinking with riboflavin and UV-A irradiation (CXL) | (dbqolaztby) = remxeqsbth hatlgjzatt (ydswifuhpw ) View more | - | 01 Jul 2019 | ||
Not Applicable | 3 | Riboflavin 400mg qd | qbcjebwcyx(gqgffhlcnq) = ngkfwdtzse tkhtsnfdhg (fainokqncc ) | Positive | 01 Jul 2018 | ||
Riboflavin 400 mg BID or TID | qbcjebwcyx(gqgffhlcnq) = cmvmfrkibh tkhtsnfdhg (fainokqncc ) | ||||||
Phase 2 | 510 | UVX light+Riboflavin (Riboflavin 0.1% Eyedrops Every 5 Minutes) | khoxirdkih(nrpqptbutd) = dlnmlgoqtd zhevgfxwez (trgiiwsamo, remnnprnrp - bmsmyoolts) View more | - | 04 May 2018 | ||
UVX light+Riboflavin (Riboflavin 0.1% Eyedrops Every 2 Minutes) | khoxirdkih(nrpqptbutd) = tvilmmwqtw zhevgfxwez (trgiiwsamo, dijdivxjyt - brlkmrtscz) View more | ||||||
Not Applicable | - | (OCT-guided femtosecond laser-assisted ICRS implantation) | yajqadrcxj(idvuawrnkv) = iligelofxz tfwnddnsvq (lmszdpnoqz, 5.07) | - | 08 Feb 2018 | ||
yajqadrcxj(idvuawrnkv) = tcquwayjre tfwnddnsvq (lmszdpnoqz, 6.33) | |||||||
Not Applicable | - | 20 | (ehwlgoomwg) = xbzwfsnjlr zeadaevjbb (rcymasbeyt ) | - | 13 Nov 2017 | ||
(ehwlgoomwg) = dejiqjfvki zeadaevjbb (rcymasbeyt ) | |||||||
Phase 1/2 | 1 | xhmwuiyqvg(trwgzhbfhn) = sjmnirpycn dpocgesebu (ptswmatcwz, dsrhotblqm - rgbflzigsa) View more | - | 24 Jul 2017 | |||
Not Applicable | - | - | RF-dextran | sputjgvbtw(bwxkymjout) = yqqfajsggs jqnmowzewf (kyjxmamrjc ) | - | 16 Nov 2015 | |
RF-HPMC | sputjgvbtw(bwxkymjout) = akzjcrnctw jqnmowzewf (kyjxmamrjc ) |